MRI Surveillance After SCLC Helps Patients Avoid Brain Irradiation
At a median follow-up of 22 months, MRI surveillance alone reduced the risk of cognitive failure or death by 40% compared to MRI plus PCI (HR 0.60; 90% CI 0.46–0.78; p=0.001). Clinical Trial Design and Patient Enrollment Metrics The trial enrolled 304 patients diagnosed with limited-stage or extensive-stage SCLC between January 2020 and December 2025, … Read more